Correlation Between CureVac NV and Enveric Biosciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both CureVac NV and Enveric Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining CureVac NV and Enveric Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between CureVac NV and Enveric Biosciences, you can compare the effects of market volatilities on CureVac NV and Enveric Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in CureVac NV with a short position of Enveric Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of CureVac NV and Enveric Biosciences.

Diversification Opportunities for CureVac NV and Enveric Biosciences

0.38
  Correlation Coefficient

Weak diversification

The 3 months correlation between CureVac and Enveric is 0.38. Overlapping area represents the amount of risk that can be diversified away by holding CureVac NV and Enveric Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enveric Biosciences and CureVac NV is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on CureVac NV are associated (or correlated) with Enveric Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enveric Biosciences has no effect on the direction of CureVac NV i.e., CureVac NV and Enveric Biosciences go up and down completely randomly.

Pair Corralation between CureVac NV and Enveric Biosciences

Given the investment horizon of 90 days CureVac NV is expected to generate 0.67 times more return on investment than Enveric Biosciences. However, CureVac NV is 1.49 times less risky than Enveric Biosciences. It trades about -0.02 of its potential returns per unit of risk. Enveric Biosciences is currently generating about -0.12 per unit of risk. If you would invest  306.00  in CureVac NV on August 31, 2024 and sell it today you would lose (19.00) from holding CureVac NV or give up 6.21% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

CureVac NV  vs.  Enveric Biosciences

 Performance 
       Timeline  
CureVac NV 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days CureVac NV has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, CureVac NV is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.
Enveric Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Enveric Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

CureVac NV and Enveric Biosciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with CureVac NV and Enveric Biosciences

The main advantage of trading using opposite CureVac NV and Enveric Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if CureVac NV position performs unexpectedly, Enveric Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enveric Biosciences will offset losses from the drop in Enveric Biosciences' long position.
The idea behind CureVac NV and Enveric Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.

Other Complementary Tools

Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals